Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease—single center experience (2019) Klobuch S, Weber D, Holler B, Edinger M, Herr W, Holler E, Wolff D Journal article Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes (2019) Balaian E, Weidner H, Wobus M, Baschant U, Jacobi A, Mies A, Bornhaeuser M, et al. Journal article Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients (2019) Lamby P, Wolff D, Mielke S, Grigoleit GU, Ljungman P, Hilgendorf I, Holler E, et al. Journal article Efficient Elimination of Cells from Patients with Different AML Subtypes by Dual-Targeting Triplebody 33-16-123 (2019) Braciak T, Fenn N, Wildenhain S, Schiller C, Roskopf C, Schubert I, Jacob U, et al. Conference contribution Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) (2017) Heinz WJ, Buchheidt D, Christopeit M, Von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, et al. Journal article, Review article Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset (2017) Bohmann EM, Fehn U, Holler B, Weber D, Holler E, Herr W, Hoffmann P, et al. Journal article Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) (2017) Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, et al. Journal article Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians (2016) Kaifie A, Isfort S, Gattermann N, Hollburg W, Klausmann M, Wolf D, Maintz C, et al. Journal article Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV (2014) Kalmanti L, Saussele S, Lauseker M, Proetel U, Mueller MC, Hanfstein B, Schreiber A, et al. Journal article